针对癌症治疗的sirtuins:表观遗传学修改和超越
Hui Shen1, Xinyi Qi2,3, Yue Hu1
1Department of Respiratory and Critical Care Medicine, Department of Outpatient, The First Hospital of China Medical University, Shenyang 110001, China.
Theranostics
|October 31, 2024
概括
赛尔图因 (SIRT) 是NAD+依赖的酶,参与表观遗传调节. 本综述探讨了它们在抑制癌症和癌症进展中的双重作用,强调了它们作为治疗点的潜力.
科学领域:
- 生物化学 生物化学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 赛尔图因 (SIRT) 是依赖尼古丁胺胺氨基二核酸 (NAD+) 的基因组脱乙酶,在细胞过程中起着至关重要的作用.
- 七个SIRT家族成员 (SIRT1-7) 呈现出不同的亚细胞局部和功能.
- SIRT涉及到各种生物过程,包括DNA修复,新陈代谢和转录.
研究的目的:
- 提供SIRT分子结构和功能的全面概述.
- 阐明SIRT与瘤发生之间的复杂关联.
- 讨论向SIRT在癌症治疗中的治疗潜力.
主要方法:
- 关于Sirtuin研究的文献评论.
- 对SIRT参与癌症抑制和进展的分析.
- 评估小分子调制剂和组合疗法.
主要成果:
- 在抑制和促进各种人类癌症方面,SIRT发挥着多方面的作用.
- SIRT1和SIRT2是核/细胞质的,而SIRT3-5是线粒体的,SIRT6-7是核的.
- 通过蛋白质脱乙烯化,SIRT调节关键细胞功能.
结论:
- 赛尔图因正在成为癌症治疗的有希望的治疗点.
- 针对SIRT的小分子激活剂和抑制剂在临床前和临床环境中显示出潜力.
- 涉及SIRT的组合疗法可能为未来的癌症药物开发提供新的策略.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


